Osteoclastogenesis and arthritis (Q37808649)

23 August 2017

Osteoclastogenesis and arthritis (English)

1 reference

23 August 2017

3

0 references

Maria Grano

2

0 references

author name string

Nicola Maruotti

1

1 reference

PubMed ID

21069419

23 August 2017

Francesca d'Onofrio

4

1 reference

PubMed ID

21069419

23 August 2017

Francesco Paolo Cantatore

5

1 reference

23 August 2017

11 November 2010

1 reference

Clinical and Experimental Medicine

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

3

1 reference

23 August 2017

137-145

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-010-0117-2

23 August 2017

0 references

cites work

Osteoclasts are essential for TNF-alpha-mediated joint destruction

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

The role of T lymphocytes in bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Osteoclasts; culprits in inflammatory osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Pathological role of osteoclast costimulation in arthritis-induced bone loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Osteoclasts, rheumatoid arthritis, and osteoimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Mechanisms of interferon-beta effects on bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Interplay between interferon and other cytokine systems in bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

A novel member of the leukocyte receptor complex regulates osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Association of the OSCAR promoter polymorphism with BMD in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Ligation of the FcR gamma chain-associated human osteoclast-associated receptor enhances the proinflammatory responses of human monocytes and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Role of ITAM-containing adapter proteins and their receptors in the immune system and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

The dynamic interplay between osteoclasts and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Connection between B lymphocyte and osteoclast differentiation pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Synovial Fluid Fibroblasts and Lymphocytes Support the Osteoclastogenesis in Human Psoriatic Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0117-2

Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

21 January 2018

1 reference

12 December 2020

Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis

1 reference

12 December 2020

IL-1 mediates TNF-induced osteoclastogenesis

1 reference

12 December 2020

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

1 reference

12 December 2020

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

12 December 2020

Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats

1 reference

12 December 2020

Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines

1 reference

12 December 2020

MafB negatively regulates RANKL-mediated osteoclast differentiation

1 reference

12 December 2020

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

1 reference

12 December 2020

Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.

1 reference

12 December 2020

Autoimmunity and bone

1 reference

12 December 2020

Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis

1 reference

12 December 2020

Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis

1 reference

12 December 2020

Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes

1 reference

12 December 2020

Interleukin-7 production by B lymphocytes affects the T cell-dependent osteoclast formation in an in vitro model derived from human periodontitis patients

1 reference

12 December 2020

Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

1 reference

12 December 2020

Activated T lymphocytes support osteoclast formation in vitro

1 reference

12 December 2020

Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma

1 reference

12 December 2020

Modulation of osteoclast differentiation

1 reference

12 December 2020

Cells expressing dendritic cell markers are present in the rheumatoid nodule

1 reference

12 December 2020

Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

1 reference

12 December 2020

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells

1 reference

12 December 2020

Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses

1 reference

12 December 2020

Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells

1 reference

12 December 2020

Murine osteoclast formation and function: differential regulation by humoral agents

1 reference

12 December 2020

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

1 reference

12 December 2020

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

12 December 2020

Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL-7 in anin vitromodel derived from human psoriatic arthritis

1 reference

12 December 2020

International union of pharmacology. XXII. Nomenclature for chemokine receptors

1 reference

12 December 2020

Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)

1 reference

12 December 2020

Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment

1 reference

12 December 2020

Bacterial-responsive B lymphocytes induce periodontal bone resorption

1 reference

12 December 2020

Dendritic cells and the pathogenesis of rheumatoid arthritis

1 reference

12 December 2020

10.1007/S10238-010-0117-2

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21069419